Down modulation of human TLR3 function by a monoclonal antibody

Cellular Immunology

Volumn 248, Issue 2, 2007, Pages 103-114

  Duffy, Karen E ^a   Lamb, Roberta J ^a   San Mateo, Lani R ^a   Jordan, Jarrat L ^a   Canziani, Gabriela ^a   Brigham Burke, Michael ^a   Korteweg, Jeremy ^a   Cunningham, Mark ^a   Beck, Heena Solanki ^a   Carton, Jill ^a   Giles Komar, Jill ^a   Duchala, Cynthia ^a   Sarisky, Robert T ^a   Mbow, M Lamine ^a  

^a CENTOCOR INC   (United States)

Author keywords

Innate immunity; Monoclonal antibody; Poly(I:C); TLR; TLR3; Toll like receptor 3

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 6; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CNTO2424; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; RECEPTOR ANTIBODY; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, MONOCLONAL; BINDING SITES, ANTIBODY; CELL LINE; CELL LINE, TRANSFORMED; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; PILOT PROJECTS; TOLL-LIKE RECEPTOR 3;

BACTERIA (MICROORGANISMS);

EID: 37349118365     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.10.002     Document Type: Article

References (18)

1. Takeda K., and Akira S. Roles of toll-like receptors in innate immune responses. Genes Cells 6 (2001) 733-742
2. Kariko K., Buckstein M., Ni H., and Weissman D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23 (2005) 165-175
3. Zarember K.A., and Godowski P.J. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168 (2002) 554-561
4. Kariko K., Ni H., Capodici J., Lamphier M., and Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279 (2004) 12542-12550
5. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature 413 (2001) 732-738
6. Sha Q., Truong-Tran A.Q., Plitt J.R., Beck L.A., and Schleimer R.P. Activation of airway epithelial cells by toll-like receptor agonists. Am. J. Respir. Cell Mol. Biol. 31 (2004) 358-364
7. Ieki K., Matsukura S., Kokubu F., Kimura T., Kuga H., Kawaguchi M., Odaka M., Suzuki S., Watanabe S., Takeuchi H., Schleimer R.P., and Adachi M. Double-stranded RNA activates RANTES gene transcription through co-operation of nuclear factor-kappaB and interferon regulatory factors in human airway epithelial cells. Clin. Exp. Allergy 34 (2004) 745-752
8. Matsumoto M., Kikkawa S., Kohase M., Miyake K., and Seya T. Establishment of a monoclonal antibody against human toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293 (2002) 1364-1369
9. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
10. de StGroth S.F., and Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J. Immunol. Methods 35 (1980) 1-21
11. Sun J., Duffy K.E., Ranjith-Kumar C.T., Xiong J., Lamb R.J., Santos J., Masarapu H., Cunningham M., Holzenburg A., Sarisky R.T., Mbow M.L., and Kao C. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation, J. Biol. Chem. 281 (2006) 11144-11151
12. Doyle S., Vaidya S., O'Connell R., Dadgostar H., Dempsey P., Wu T., Rao G., Sun R., Haberland M., Modlin R., and Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17 (2002) 251-263
13. Schafer S.L., Lin R., Moore P.A., Hiscott J., and Pitha P.M. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273 (1998) 2714-2720
14. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., and Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17 (1998) 1087-1095
15. Guillot L., Le Goffic R., Bloch S., Escriou N., Akira S., Chignard M., and Si-Tahar M. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J. Biol. Chem. 280 (2005) 5571-5580
16. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., Taira K., Akira S., and Fujita T. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5 (2004) 730-737
17. Sen G.C., and Sarkar S.N. Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev. 16 (2005) 1-14
18. Der S.D., and Lau A.S. Involvement of the double-stranded-RNA-dependent kinase PKR in interferon expression and interferon-mediated antiviral activity. Proc. Natl. Acad. Sci. USA 92 (1995) 8841-8845